These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1156036)

  • 1. The effects of 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo (2, 1-a) isoindole (mazindol, SaH 42-548) on the metabolism of brain norepinephrine.
    Engstrom RG; Kelly LA; Gogerty JH
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):308-21. PubMed ID: 1156036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological analysis of a new anorexic substance: 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo-(2, 1-a) isoindole (Mazindol).
    Gogerty JH; Penberthy C; Iorio LC; Trapold JH
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):285-307. PubMed ID: 1171662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anorexic and behavioural effects of a new imidazo-isoindole derivative (mazindol) in comparison with d-amphetamine in the rat.
    Babbini M; Gaiardi M; Bartoletti M
    Pharmacology; 1977; 15(1):46-56. PubMed ID: 557207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
    Eisenhofer G; Finberg JP
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected differences between mazindol and its homologs on biochemical and behavioral responses.
    Heikkila RE; Cabbat FS; Manzino L; Babington RG; Houlihan WJ
    J Pharmacol Exp Ther; 1981 Jun; 217(3):745-9. PubMed ID: 7194909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
    Samanin R; Bendotti C; Bernasconi S; Borroni E; Garattini S
    Eur J Pharmacol; 1977 May; 43(2):117-24. PubMed ID: 872869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of amphetamine on brain catecholamines, brain beta-endorphin, serum prolactin, catechol-O-methyltransferase and monoamine oxidase of various organs in the rat.
    Agarwal DP; Hoo JJ; Tjaden A; Nishigaki I; Beckermann WJ; Pahnke V; Goedde HW
    Arzneimittelforschung; 1985; 35(11):1639-42. PubMed ID: 2936351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mazindol on feeding behaviour and on noradrenergic function of various parts of the rat brain.
    Halmy L; Nyakas C; Walter J
    Acta Physiol Acad Sci Hung; 1982; 59(4):341-7. PubMed ID: 7170986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate.
    Carruba MO; Groppetti A; Mantegazza P; Vicentini L; Zambotti F
    Br J Pharmacol; 1976 Apr; 56(4):431-6. PubMed ID: 1260223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some effects of mazindol, an anorectic drug, on rat brain monoaminergic systems.
    Sugrue MF; Shaw G; Charlton KG
    Eur J Pharmacol; 1977 Apr; 42(4):379-85. PubMed ID: 856614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium-induced release of [3H]catecholamine from brain: effects of pre-exposure to catecholamine uptake inhibitors.
    Dembiec D; Cohen G
    J Pharmacol Exp Ther; 1981 Jun; 217(3):727-32. PubMed ID: 7230001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies with several analogs of mazindol: correlation between effects on dopamine uptake and various in vivo responses.
    Heikkila RE; Babington RG; Houlihan WJ
    Eur J Pharmacol; 1981 May; 71(2-3):277-86. PubMed ID: 7250190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some effects of mazindol on the metabolism of monoamines in the rat brain [proceedings].
    Charlton KG; Sugrue MF
    Br J Pharmacol; 1976 Oct; 58(2):271P. PubMed ID: 974392
    [No Abstract]   [Full Text] [Related]  

  • 15. The role if dopamine and norepinephrine uptake inhibition in mediating the central effects of d-amphetamine in vivo.
    Feigenbaum JJ; Yanai J; Blass RB
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):333-5. PubMed ID: 7071417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinations of selected CNS depressants with d-amphetamine or mazindol on food intake and motor activity of rats.
    Iorio LC; Ryan EA; Gogerty JH
    Eur J Pharmacol; 1976 Mar; 36(1):89-94. PubMed ID: 1261608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1988 Apr; 245(1):199-210. PubMed ID: 3129549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanisms by which amphetamine inhibits oxidative deamination of norepinephrine in brain.
    Rutledge CO
    J Pharmacol Exp Ther; 1970 Feb; 171(2):188-95. PubMed ID: 5413739
    [No Abstract]   [Full Text] [Related]  

  • 19. Supersensitivity to catecholamines after impairment of extraneuronal uptake or catechol-O-methyl transferase.
    Trendelenburg U; Graefe KH
    Fed Proc; 1975 Sep; 34(10):1971-4. PubMed ID: 169167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.